Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response

Bibliographic Details
Published in:	Haematologica
Main Authors:	Massimiliano Bonifacio, Gianni Binotto, Elena Maino, Elisabetta Calistri, Luciana Marin, Luigi Scaffidi, Luca Frison, Federico De Marchi, Mauro Krampera, Giampiero Semenzato, Renato Fanin, Achille Ambrosetti, Mario Tiribelli
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2015-08-01
Online Access:	https://haematologica.org/article/view/7473

Internet